Beta Wealth Group’s Oncternal Therapeutics, Inc. Common Stock ONCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-1,600
| Closed | -$17.2K | – | 110 |
|
|
2023
Q4 | $17.2K | Hold |
1,600
| – | – | 0.01% | 105 |
|
|
2023
Q3 | $9.6K | Hold |
1,600
| – | – | 0.01% | 99 |
|
|
2023
Q2 | $11K | Hold |
1,600
| – | – | 0.01% | 100 |
|
|
2023
Q1 | $25.1K | Hold |
1,600
| – | – | 0.01% | 100 |
|
|
2022
Q4 | $32K | Hold |
1,600
| – | – | 0.02% | 98 |
|
|
2022
Q3 | $29K | Hold |
1,600
| – | – | 0.02% | 89 |
|
|
2022
Q2 | $36K | Hold |
1,600
| – | – | 0.02% | 87 |
|
|
2022
Q1 | $44K | Buy |
+1,600
| New | +$44K | 0.03% | 91 |
|